S&P 500   4,265.93 (-0.52%)
DOW   33,306.87 (-0.60%)
QQQ   358.83 (+0.16%)
AAPL   172.85 (+0.96%)
MSFT   318.78 (+0.96%)
META   303.56 (+1.12%)
GOOGL   133.19 (+1.78%)
AMZN   128.86 (+1.37%)
TSLA   248.51 (-0.68%)
NVDA   443.66 (+1.99%)
NIO   8.71 (-3.65%)
BABA   86.15 (-0.68%)
AMD   101.94 (-0.86%)
T   14.68 (-2.26%)
F   12.23 (-1.53%)
MU   67.18 (-1.25%)
CGC   0.73 (-6.43%)
GE   108.58 (-1.78%)
DIS   81.40 (+0.43%)
AMC   8.12 (+1.63%)
PFE   33.75 (+1.75%)
PYPL   58.39 (-0.12%)
NFLX   379.16 (+0.41%)
S&P 500   4,265.93 (-0.52%)
DOW   33,306.87 (-0.60%)
QQQ   358.83 (+0.16%)
AAPL   172.85 (+0.96%)
MSFT   318.78 (+0.96%)
META   303.56 (+1.12%)
GOOGL   133.19 (+1.78%)
AMZN   128.86 (+1.37%)
TSLA   248.51 (-0.68%)
NVDA   443.66 (+1.99%)
NIO   8.71 (-3.65%)
BABA   86.15 (-0.68%)
AMD   101.94 (-0.86%)
T   14.68 (-2.26%)
F   12.23 (-1.53%)
MU   67.18 (-1.25%)
CGC   0.73 (-6.43%)
GE   108.58 (-1.78%)
DIS   81.40 (+0.43%)
AMC   8.12 (+1.63%)
PFE   33.75 (+1.75%)
PYPL   58.39 (-0.12%)
NFLX   379.16 (+0.41%)
S&P 500   4,265.93 (-0.52%)
DOW   33,306.87 (-0.60%)
QQQ   358.83 (+0.16%)
AAPL   172.85 (+0.96%)
MSFT   318.78 (+0.96%)
META   303.56 (+1.12%)
GOOGL   133.19 (+1.78%)
AMZN   128.86 (+1.37%)
TSLA   248.51 (-0.68%)
NVDA   443.66 (+1.99%)
NIO   8.71 (-3.65%)
BABA   86.15 (-0.68%)
AMD   101.94 (-0.86%)
T   14.68 (-2.26%)
F   12.23 (-1.53%)
MU   67.18 (-1.25%)
CGC   0.73 (-6.43%)
GE   108.58 (-1.78%)
DIS   81.40 (+0.43%)
AMC   8.12 (+1.63%)
PFE   33.75 (+1.75%)
PYPL   58.39 (-0.12%)
NFLX   379.16 (+0.41%)
S&P 500   4,265.93 (-0.52%)
DOW   33,306.87 (-0.60%)
QQQ   358.83 (+0.16%)
AAPL   172.85 (+0.96%)
MSFT   318.78 (+0.96%)
META   303.56 (+1.12%)
GOOGL   133.19 (+1.78%)
AMZN   128.86 (+1.37%)
TSLA   248.51 (-0.68%)
NVDA   443.66 (+1.99%)
NIO   8.71 (-3.65%)
BABA   86.15 (-0.68%)
AMD   101.94 (-0.86%)
T   14.68 (-2.26%)
F   12.23 (-1.53%)
MU   67.18 (-1.25%)
CGC   0.73 (-6.43%)
GE   108.58 (-1.78%)
DIS   81.40 (+0.43%)
AMC   8.12 (+1.63%)
PFE   33.75 (+1.75%)
PYPL   58.39 (-0.12%)
NFLX   379.16 (+0.41%)
NASDAQ:TRUP

Trupanion (TRUP) Stock Forecast, Price & News

$27.60
-0.60 (-2.13%)
(As of 02:45 PM ET)
Compare
Today's Range
$27.29
$28.40
50-Day Range
$26.61
$33.12
52-Week Range
$18.45
$69.15
Volume
490,949 shs
Average Volume
979,551 shs
Market Capitalization
$1.14 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$48.38

Trupanion MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.57 Rating Score
Upside/​Downside
75.0% Upside
$48.38 Price Target
Short Interest
Bearish
30.59% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.61
Upright™ Environmental Score
News Sentiment
0.69mentions of Trupanion in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$260,553 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.51) to ($0.56) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.69 out of 5 stars

Finance Sector

759th out of 878 stocks

Hospital & Medical Service Plans Industry

11th out of 11 stocks


TRUP stock logo

About Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.

TRUP Price History

TRUP Stock News Headlines

What More Does Chewy Have to Do to Impress Investors? (TRUP)
Chewy, Inc. has several challenges to work through as it adjusts to a normalized consumer spending backdrop and inflation
Piper Sandler Keeps Their Hold Rating on Trupanion (TRUP)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Trupanion, Inc. (TPW.F)
Trupanion: Q2 Earnings Snapshot
American Pet Insurance Review 2023
Earnings Preview For Trupanion
See More Headlines
Receive TRUP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trupanion and its competitors with MarketBeat's FREE daily newsletter.

TRUP Company Calendar

Last Earnings
8/03/2023
Today
10/02/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
N/A
Sector
Finance
Current Symbol
NASDAQ:TRUP
Employees
1,187
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$48.38
High Stock Price Forecast
$72.00
Low Stock Price Forecast
$32.00
Forecasted Upside/Downside
+71.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
7 Analysts

Profitability

Net Income
$-44,670,000.00
Pretax Margin
-6.02%

Debt

Sales & Book Value

Annual Sales
$905.18 million
Book Value
$7.47 per share

Miscellaneous

Free Float
38,995,000
Market Cap
$1.17 billion
Optionable
Optionable
Beta
1.71
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Darryl Graham Andrew Rawlings (Age 54)
    Founder, CEO & Chair of the Board
    Comp: $300k
  • Ms. Margaret Rosemary Maria Tooth (Age 44)
    Pres
    Comp: $300k
  • Ms. Emily Dreyer (Age 35)
    Sr. VP of Channel Growth
    Comp: $261.87k
  • Mr. Wei Li
    Exec. VP, Interim CFO & Corp. Controller
  • Ms. Brenna McGibney (Age 54)
    Chief Admin. Officer
  • Ms. Laura Bainbridge
    VP of Corp. Communications
  • Dr. Steve Weinrauch BVMS (Age 48)
    MRCVS, Exec. VP of North America & Veterinary Strategy
  • Ms. Bradley Lamb
    Head of Conversion
  • Mr. John Gallagher (Age 36)
    Exec. VP of Global Support Services
  • Mr. Shawn McWashington
    Head of Corp. Group Benefits













TRUP Stock - Frequently Asked Questions

Should I buy or sell Trupanion stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" TRUP shares.
View TRUP analyst ratings
or view top-rated stocks.

What is Trupanion's stock price forecast for 2023?

7 equities research analysts have issued 1-year target prices for Trupanion's shares. Their TRUP share price forecasts range from $32.00 to $72.00. On average, they predict the company's share price to reach $48.38 in the next twelve months. This suggests a possible upside of 71.5% from the stock's current price.
View analysts price targets for TRUP
or view top-rated stocks among Wall Street analysts.

How have TRUP shares performed in 2023?

Trupanion's stock was trading at $47.53 at the beginning of the year. Since then, TRUP stock has decreased by 40.7% and is now trading at $28.20.
View the best growth stocks for 2023 here
.

When is Trupanion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our TRUP earnings forecast
.

How were Trupanion's earnings last quarter?

Trupanion, Inc. (NASDAQ:TRUP) released its earnings results on Thursday, August, 3rd. The financial services provider reported ($0.33) EPS for the quarter, topping analysts' consensus estimates of ($0.42) by $0.09. The financial services provider had revenue of $270.60 million for the quarter, compared to the consensus estimate of $262.81 million. Trupanion had a negative trailing twelve-month return on equity of 20.32% and a negative net margin of 6.03%. The company's revenue for the quarter was up 23.3% on a year-over-year basis. During the same period in the previous year, the business earned ($0.33) EPS.

What ETFs hold Trupanion's stock?

ETFs with the largest weight of Trupanion (NASDAQ:TRUP) stock in their portfolio include ProShares Pet Care ETF (PAWZ), Inspire Small/Mid Cap ETF (ISMD) and iShares U.S. Insurance ETF (IAK).Noble Absolute Return ETF (NOPE).

What guidance has Trupanion issued on next quarter's earnings?

Trupanion updated its third quarter 2023 earnings guidance on Friday, August, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $270.00 million-$275.00 million, compared to the consensus revenue estimate of $270.16 million.

What is Darryl Rawlings' approval rating as Trupanion's CEO?

139 employees have rated Trupanion Chief Executive Officer Darryl Rawlings on Glassdoor.com. Darryl Rawlings has an approval rating of 76% among the company's employees.

What other stocks do shareholders of Trupanion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trupanion investors own include CA (CA), Micron Technology (MU), Chipotle Mexican Grill (CMG), McEwen Mining (MUX), Pfizer (PFE), Splunk (SPLK), AbbVie (ABBV), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

What is Trupanion's stock symbol?

Trupanion trades on the NASDAQ under the ticker symbol "TRUP."

How do I buy shares of Trupanion?

Shares of TRUP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trupanion's stock price today?

One share of TRUP stock can currently be purchased for approximately $28.20.

How much money does Trupanion make?

Trupanion (NASDAQ:TRUP) has a market capitalization of $1.17 billion and generates $905.18 million in revenue each year. The financial services provider earns $-44,670,000.00 in net income (profit) each year or ($1.48) on an earnings per share basis.

How many employees does Trupanion have?

The company employs 1,187 workers across the globe.

How can I contact Trupanion?

Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The official website for the company is www.trupanion.com. The financial services provider can be reached via phone at (855) 727-9079, via email at investorrelations@trupanion.com, or via fax at 866-405-4536.

This page (NASDAQ:TRUP) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -